je.st
news
In a twist, Teva to face generic competition
2015-04-17 00:07:31| Biotech - Topix.net
The Food and Drug Administration on Thursday approved the first generic version of Teva's top branded product, the multiple sclerosis drug Copaxone. Teva , based in Israel with its North American headquarters in North Wales, Pa., had spent several years in court battles trying to fend off competition for its MS drug.
Tags: face
competition
generic
twist
Category:Biotechnology and Pharmaceuticals